Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Salicylate, Sodium
1. 54-21-7
2. Sodium 2-hydroxybenzoate
3. Enterosalicyl
4. Kerasalicyl
5. Clin
6. Alysine
7. Salsonin
8. Benzoic Acid, 2-hydroxy-, Monosodium Salt
9. Enterosalil
10. Entrosalyl
11. Glutosalyl
12. Magsalyl
13. Aroall
14. Kerosal
15. Nadisal
16. Salisod
17. Idocyl Novum
18. Neo-salicyl
19. Natrum Salicylicum
20. Monosodium Salicylate
21. Salicylic Acid Sodium Salt
22. Diuretin
23. Parbocyl-rev
24. Sodium;2-hydroxybenzoate
25. Salicylate Sodium
26. Salicylic Acid, Sodium Salt
27. Sodium O-hydroxybenzoate
28. Salicylic Acid Sodium
29. Wiq1h85syp
30. O-hydroxybenzoic Acid, Sodium Salt
31. Chebi:9180
32. Nsc-202167
33. 90218-97-6
34. Benzoic Acid, 2-hydroxy-, Monosodium Salt, Coupled With 4-amino-1-naphthalenesulfonic Acid And Diazotized 2-(4-aminophenyl)-1h-benzimidazol-5-amine, Sodium Salt
35. Salicylic Acid Sodium Salt;2-hydroxybenzoic Acid Sodium Salt
36. Natrium Salicylat [german]
37. Ccris 6715
38. Einecs 200-198-0
39. Unii-wiq1h85syp
40. Nsc 202167
41. Sodium Salicylate [usp:jan]
42. Natrii Salicylas
43. Mfcd00002440
44. Sodium;2-carboxyphenolate
45. Sodium Salicylate, 99%
46. Spectrum2_001945
47. Spectrum3_000900
48. Spectrum4_000995
49. Spectrum5_001120
50. Dsstox_cid_1708
51. Ec 200-198-0
52. Schembl4603
53. Dsstox_rid_76287
54. Dsstox_gsid_21708
55. Kbiogr_001429
56. 90218-94-3
57. Spectrum1500533
58. Spbio_002009
59. Chembl447868
60. Sodium Salicylate [jan]
61. Dtxsid5021708
62. Sodium Salicylate (jp17/usp)
63. Sodium Salicylate [inci]
64. Hy-b0167a
65. Kbio3_001820
66. Natrum Salicylicum [hpus]
67. Sodium Salicylate [vandf]
68. Sodium Salicylate [mart.]
69. Hms1920p16
70. Hms2092g17
71. Salicylate Sodium [who-dd]
72. Sodium Salicylate [usp-rs]
73. Sodium Salicylate [who-ip]
74. Sodium Salicylate, P.a., 99.5%
75. Tox21_200411
76. 2-hydroxy Benzoic Acid, Sodium Salt
77. Ccg-39474
78. Akos003051698
79. Akos005766021
80. Cs-2008
81. Cas-54-21-7
82. Natrii Salicylas [who-ip Latin]
83. Salicylic Acid Sodium Salt [mi]
84. Sodium Salicylate [ep Monograph]
85. Ncgc00094780-01
86. Ncgc00094780-02
87. Ncgc00257965-01
88. Sodium Salicylate [usp Monograph]
89. Db-052516
90. Ft-0631235
91. C07587
92. D00566
93. D83111
94. Sodium Salicylate, Reagentplus(r), >=99.5%
95. Sodium Salicylate, Saj First Grade, >=99.5%
96. Sodium Salicylate, Tested According To Ph.eur.
97. Sodium Salicylate, Saj Special Grade, >=99.5%
98. 2,4-dimethoxyphenylboronicacid,pinacolester
99. Q414547
100. Sodium Salicylate, Vetec(tm) Reagent Grade, 99%
101. Sodium Salicylate, Meets Usp Testing Specifications
102. Sodium Salicylate, Puriss. P.a., >=99.5% (nt)
103. Sodium Salicylate, European Pharmacopoeia (ep) Reference Standard
104. Sodium Salicylate, United States Pharmacopeia (usp) Reference Standard
105. Benzoic Acid,2-hydroxy-,monosodium Salt,coupled With 4-amino-5-hydroxy-2,7-naphthalenedisulfonic Acid,diazotized 2-(4-aminophenyl)-1h-benzimidazol-5-amine And Diazotized 4-nitrobenzenamine,sodium
106. Sodium Salicylate, Puriss. P.a., Reag. Ph. Eur., 99.5-101.0% (calc. To The Dried Substance)
Molecular Weight | 160.10 g/mol |
---|---|
Molecular Formula | C7H5NaO3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 1 |
Exact Mass | 160.01363830 g/mol |
Monoisotopic Mass | 160.01363830 g/mol |
Topological Polar Surface Area | 60.4 Ų |
Heavy Atom Count | 11 |
Formal Charge | 0 |
Complexity | 138 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Cyclooxygenase Inhibitors
Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)
N - Nervous system
N02 - Analgesics
N02B - Other analgesics and antipyretics
N02BA - Salicylic acid and derivatives
N02BA04 - Sodium salicylate
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Sodium Salicylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sodium Salicylate, including repackagers and relabelers. The FDA regulates Sodium Salicylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sodium Salicylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sodium Salicylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sodium Salicylate supplier is an individual or a company that provides Sodium Salicylate active pharmaceutical ingredient (API) or Sodium Salicylate finished formulations upon request. The Sodium Salicylate suppliers may include Sodium Salicylate API manufacturers, exporters, distributors and traders.
click here to find a list of Sodium Salicylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Sodium Salicylate DMF (Drug Master File) is a document detailing the whole manufacturing process of Sodium Salicylate active pharmaceutical ingredient (API) in detail. Different forms of Sodium Salicylate DMFs exist exist since differing nations have different regulations, such as Sodium Salicylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Sodium Salicylate DMF submitted to regulatory agencies in the US is known as a USDMF. Sodium Salicylate USDMF includes data on Sodium Salicylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Sodium Salicylate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Sodium Salicylate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Sodium Salicylate Drug Master File in Japan (Sodium Salicylate JDMF) empowers Sodium Salicylate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Sodium Salicylate JDMF during the approval evaluation for pharmaceutical products. At the time of Sodium Salicylate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Sodium Salicylate suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Sodium Salicylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Sodium Salicylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Sodium Salicylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Sodium Salicylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Sodium Salicylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Sodium Salicylate suppliers with NDC on PharmaCompass.
Sodium Salicylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sodium Salicylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sodium Salicylate GMP manufacturer or Sodium Salicylate GMP API supplier for your needs.
A Sodium Salicylate CoA (Certificate of Analysis) is a formal document that attests to Sodium Salicylate's compliance with Sodium Salicylate specifications and serves as a tool for batch-level quality control.
Sodium Salicylate CoA mostly includes findings from lab analyses of a specific batch. For each Sodium Salicylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sodium Salicylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Sodium Salicylate EP), Sodium Salicylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sodium Salicylate USP).
LOOKING FOR A SUPPLIER?